MedTrace Logo

Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai

NCT03987945 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-06-17

No results posted yet for this study

Summary

The prognostic implication of left atrial appendage occlusion (LAAO) procedure in non-valvular atrial fibrillation (NVAF) patients from China is still unclear. We aim to investigate the impact of LAAO procedure on subsequent clinical outcomes in patients from China.

Conditions

Interventions

DEVICE

left atrial appendage occlusion devices

All NVAF patients who are admitted for receiving left atrial appendage occlusion procedure, including Watchman, LAmbre, Lefort, and Leftear deveices.

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yawei Xu, M.D., Ph.D. · Department of Cardiology, Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987945 on ClinicalTrials.gov